1. Home
  2. KNSA vs ARHS Comparison

KNSA vs ARHS Comparison

Compare KNSA & ARHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KNSA
  • ARHS
  • Stock Information
  • Founded
  • KNSA 2015
  • ARHS 1986
  • Country
  • KNSA United Kingdom
  • ARHS United States
  • Employees
  • KNSA N/A
  • ARHS N/A
  • Industry
  • KNSA Biotechnology: Pharmaceutical Preparations
  • ARHS Other Specialty Stores
  • Sector
  • KNSA Health Care
  • ARHS Consumer Discretionary
  • Exchange
  • KNSA Nasdaq
  • ARHS Nasdaq
  • Market Cap
  • KNSA 1.7B
  • ARHS 1.5B
  • IPO Year
  • KNSA 2018
  • ARHS 2021
  • Fundamental
  • Price
  • KNSA $26.79
  • ARHS $8.89
  • Analyst Decision
  • KNSA Strong Buy
  • ARHS Buy
  • Analyst Count
  • KNSA 5
  • ARHS 12
  • Target Price
  • KNSA $33.60
  • ARHS $14.33
  • AVG Volume (30 Days)
  • KNSA 283.3K
  • ARHS 1.4M
  • Earning Date
  • KNSA 10-29-2024
  • ARHS 10-31-2024
  • Dividend Yield
  • KNSA N/A
  • ARHS N/A
  • EPS Growth
  • KNSA N/A
  • ARHS N/A
  • EPS
  • KNSA N/A
  • ARHS 0.63
  • Revenue
  • KNSA $338,930,000.00
  • ARHS $1,275,200,000.00
  • Revenue This Year
  • KNSA $58.95
  • ARHS $0.33
  • Revenue Next Year
  • KNSA $36.22
  • ARHS $7.97
  • P/E Ratio
  • KNSA N/A
  • ARHS $14.13
  • Revenue Growth
  • KNSA 20.69
  • ARHS N/A
  • 52 Week Low
  • KNSA $14.12
  • ARHS $7.56
  • 52 Week High
  • KNSA $27.92
  • ARHS $19.81
  • Technical
  • Relative Strength Index (RSI)
  • KNSA 58.67
  • ARHS 25.31
  • Support Level
  • KNSA $23.33
  • ARHS $9.34
  • Resistance Level
  • KNSA $27.35
  • ARHS $9.78
  • Average True Range (ATR)
  • KNSA 0.89
  • ARHS 0.42
  • MACD
  • KNSA 0.15
  • ARHS -0.15
  • Stochastic Oscillator
  • KNSA 86.07
  • ARHS 4.28

About KNSA Kiniksa Pharmaceuticals Ltd.

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.

About ARHS Arhaus Inc.

Arhaus Inc is a growing lifestyle brand and omnichannel retailer of premium home furniture. The company offers merchandise in a number of categories, including furniture, outdoor, lighting, textiles, and decor through its Retail and eCommerce sales channels.

Share on Social Networks: